Windle Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Sell
45,007
-491
-1% -$114K 4.65% 3
2025
Q4
$9.42M Sell
45,498
-2,096
-4% -$414K 4.22% 7
2025
Q3
$8.82M Sell
47,594
-228
-0.5% -$39.1K 3.95% 8
2025
Q2
$7.3M Sell
47,822
-702
-1% -$108K 3.57% 19
2025
Q1
$8.05M Buy
48,524
+2,868
+6% +$449K 4.14% 13
2024
Q4
$6.6M Buy
45,656
+2,580
+6% +$400K 3.65% 18
2024
Q3
$6.98M Buy
43,076
+1,539
+4% +$245K 3.79% 17
2024
Q2
$6.07M Buy
41,537
+3,003
+8% +$447K 3.7% 20
2024
Q1
$6.1M Buy
38,534
+1,332
+4% +$212K 3.88% 21
2023
Q4
$5.83M Buy
37,202
+1,266
+4% +$194K 4.09% 16
2023
Q3
$5.6M Buy
35,936
+1,338
+4% +$221K 4.17% 16
2023
Q2
$5.73M Buy
34,598
+533
+2% +$86K 4.13% 15
2023
Q1
$5.28M Buy
34,065
+838
+3% +$135K 3.91% 18
2022
Q4
$5.87M Buy
+33,227
New +$5.74M 4.58% 9

Other funds holding JNJ

Windle Wealth's JNJ Position: Q1 2026 in Review

Windle Wealth reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, selling an estimated $114K and leaving 45,007 shares worth $11M. The position accounts for 4.65% of the portfolio, ranked #3.

Windle Wealth first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Windle Wealth held 45,007 shares of Johnson & Johnson worth $11M as of Q1 2026.
  • Windle Wealth sold 491 Johnson & Johnson shares in Q1 2026, an estimated $114K.
  • Johnson & Johnson made up 4.65% of Windle Wealth's portfolio in Q1 2026, its #3 holding.
  • Windle Wealth first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Windle Wealth's 13F filing for Q1 2026, filed 11 May 2026.